Comparative Studies of Bone Graft and Orthobiologics for Foot Ankle Arthrodesis: A Critical Review.

J Am Acad Orthop Surg Glob Res Rev · May 01 2024 · Review

Bolia IK, Covell DJ, Tan EW

From the Department of Orthopeadic Surgery, Keck School of Medicine, University of Southern California, KY (Dr. Covell)

Foot & Ankle

SUMMARY — THE REDUCTIONBone grafts and orthobiologic agents show variable efficacy for ankle/hindfoot arthrodesis; limited comparative evidence exists to guide material selection.
Abstract, as published

Graft materials available to supplement hindfoot and ankle arthrodesis procedures include autologous (autograft) or allogeneic bone graft (allograft) but also bone graft substitutes such as demineralized bone matrix, calcium sulfate, calcium phosphate, and tricalcium phosphate/hydroxyapatite. In addition, biologic agents, such as recombinant human bone morphogenetic protein-2 or recombinant human platelet derived growth factor-BB (rhPDGF-BB), and preparations, including platelet-rich plasma or concentrated bone marrow aspirate, have been used to facilitate bone healing in ankle or hindfoot arthrodesis. The purpose of this review was to summarize the available clinical evidence surrounding the utilization and efficacy of the above materials and biological agents in ankle or hindfoot arthrodesis procedures, with emphasis on the quality of the existing evidence to facilitate clinical decision making.

Featured in the 2026-06-28 issue.

← Prospective Controlled Trial of STAR Total Ankle Replacement …Revision of Recurrent Hallux Valgus. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.